Atlanta Braves Holdings, Inc. (BATRK) insider details RSU vesting sale

Rhea-AI Filing Summary

Atlanta Braves Holdings, Inc. reported equity transactions by a company executive serving as EVP, Chief People & Culture Officer. On December 11, 2025, 1,880 restricted stock units converted into an equal number of Series C Common Stock shares at $0 per share. On December 12, 2025, 826 Series C shares were sold at a weighted average price of $39.71 to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Following these transactions, the executive directly owned 6,040 Series C Common Stock shares and 1,881 remaining restricted stock units. The RSU award vests in three equal installments, with one-third having vested on December 11, 2024 and 2025, and the final third scheduled to vest on December 11, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rhodes DeRetta C.

(Last) (First) (Middle)

C/O ATLANTA BRAVES HOLDINGS, INC.

755 BATTERY AVENUE SE

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Atlanta Braves Holdings, Inc. [ BATRK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Series C Common Stock	12/11/2025		M		1,880	A	$0(1)	6,866	D
Series C Common Stock	12/12/2025		S(2)		826	D	$39.71(3)	6,040	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units - BATRK	(4)	12/11/2025		M			1,880	(5)	(5)	Series C Common Stock	1,880	$0	1,881	D

Explanation of Responses:

1. Each restricted stock unit converted into one share of Series C Common Stock.

2. The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

3. Reflects the weighted average sale price. The range of prices for such transaction is $39.41 to $40.04. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

4. Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

5. One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

Remarks:

EVP, Chief People & Culture Officer

	/s/ Kerry T. Wenzel, Attorney-in-Fact	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Atlanta Braves Holdings, Inc. (BATRK) report in this Form 4?

The filing shows an executive serving as EVP, Chief People & Culture Officer had 1,880 restricted stock units convert into Series C Common Stock on December 11, 2025, and sold 826 Series C shares on December 12, 2025.

How many Atlanta Braves Holdings Series C shares were acquired from RSUs and at what price?

A total of 1,880 Series C Common Stock shares were acquired upon RSU conversion at a price of $0 per share, reflecting the nature of restricted stock unit settlement.

Why were 826 Atlanta Braves Holdings (BATRK) shares sold on December 12, 2025?

The 826 Series C Common Stock shares sold on December 12, 2025 were reported as being sold by the executive to cover tax withholding obligations related to the vesting and settlement of the restricted stock units.

What price did the Atlanta Braves Holdings executive receive for the 826 shares sold?

The sale of 826 Series C Common Stock shares was executed at a weighted average price of $39.71 per share, within a price range of $39.41 to $40.04.

What is the executive’s remaining ownership in Atlanta Braves Holdings Series C stock after these transactions?

After the reported transactions, the executive directly owned 6,040 shares of Series C Common Stock and held 1,881 remaining restricted stock units.

What is the vesting schedule for the restricted stock units in this Atlanta Braves Holdings (BATRK) filing?

The restricted stock unit award vests in three equal parts: one-third vested on December 11, 2024, another one-third vested on December 11, 2025, and the remaining RSUs are scheduled to vest on December 11, 2026.